DEVELOPMENT AND VALIDATION OF A SIMPLE, RAPID AND ROBUST RP-HPLC METHOD FOR THE ESTIMATION OF MOLNUPIRAVIR IN BULK DRUG AND MARKETED CAPSULE FORMULATION
Background: Molnupiravir is an orally active antiviral nucleoside analogue prodrug used for the management of COVID-19. The development of a reliable, rapid and reproducible analytical method is essential for the quality control of Molnupiravir bulk drug and pharmaceutical formulations. Objective: The present study aimed to develop and validate a reverse-phase high-performance liquid chromatographic (RP-HPLC) method for the quantitative determination of Molnupiravir in bulk drug and marketed capsule formulation. Methods: Chromatographic separation of Molnupiravir was performed using a reversed-phase C18 analytical column. The developed method was evaluated for system suitability, linearity, accuracy, precision, robustness, ruggedness, limit of detection (LOD), limit of quantification (LOQ), and assay of the marketed formulation in accordance with analytical method-validation principles. Linearity was evaluated over 10–50 µg/mL. Accuracy was investigated at 80%, 100%, and 120% concentration levels. Precision was evaluated through repeatability and intra-day/inter-day studies. Results: The developed method exhibited satisfactory chromatographic performance with a retention time of approximately 3.6 min. The calibration response was evaluated over 10–50 µg/mL. The LOD and LOQ were found to be 0.4548 and 1.3782 µg/mL, respectively. Recovery studies were within 98–102%. Repeatability demonstrated 101.34% mean assay with %RSD of 1.44. Analysis of Molnatris® 200 mg capsules showed 99.51% label claim with %RSD of 0.064. Ruggedness studies using different analysts showed acceptable reproducibility. Conclusion: The developed RP-HPLC method demonstrated satisfactory linearity, accuracy, precision, sensitivity, robustness and ruggedness and can be considered suitable for routine quantitative analysis of Molnupiravir in bulk drug and marketed capsule formulation.
Authors
- Rupesh Pingale
- Gouri Palsokar
- Gaurav Subhash Gosavi
Institutions
- Sterling Research Group (US)
Publication Details
- Journal
- International Journal of Drug Delivery Technology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.25258/ijddt.16.80s.108
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00